U.S. Patent Granted for Cynata Cymerus™ Technology
Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), is pleased to announce that the U.S. Patent and Trademark Office (USPTO) has granted a patent covering aspects of Cynata’s proprietary Cymerus™ mesenchymal stem cell technology.…
St Vincent’s Hospital Commences Global First APAS® In Situ Automated Evaluation
Australian developed advanced pathology instrument reading and interpreting plates for faster diagnosis of infectious diseases Centre of excellence laboratory to test automation efficiency in a busy real-life setting Adelaide, Australia, 27 September 2017: Australian medical technology…
5th October – BioWorkshop – Global Pathways to Pre-Clinical Development Success
Learn approaches on how to design your pre-clinical studies from the experts! This workshop will cover global technical and regulatory strategies for pre-clinical development of medicines, from small molecules and biologics, to cell and gene therapies. Attendees will…
Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria
September 2017 Continued Discussions : Pharmaceutical Manufacturing: Driving Competitive Advantage for Victoria BioMelbourne Network convened a roundtable with Minister Wade Noonan, Minister Philip Dalidakis and 14 pharmaceutical and biotechnology companies who currently manufacture or develop products for manufacture…
Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics
We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…
Ask Industry Anything (Again) – Tuesday 28th November 2017
BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…
Hydrix & Panorama
Today it was announced that Panorama Synergy Limited (ASX: PSY) has entered into an agreement to fully acquire Hydrix through an asset purchase agreement. This is an exciting development for both companies with the Merged Group at the…
BTF – Medical technology investment to improve lives
The Turnbull Government will fund three medical breakthroughs to help people with severe disabilities walk again and support thousands of Australians facing crippling chronic back pain.A total of $13.3 million will be invested into high potential Australian innovations…
Victorian patients with frontotemporal dementia to trial new drug
IN a world-first trial, Victorians with a devastating form of dementia that strikes in middle age will be given a drug aimed at slowing the disease. Thousands of Australians have the condition, which causes changes in personality and…
Discovery Award to support new test for sepsis
Burnet Institute’s Global Health Diagnostics Laboratory has been awarded a prestigious Longitude Prize Discovery Award to facilitate the development of a laboratory-based sepsis assay into a point-of-care test. The award will also support the Laboratory’s bid for a…
BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017
With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…
Attention all Victorians attending AusBiotech 2017 in Adelaide
The Victorian Government will be hosting a stand in the Exhibition Hall for the duration of the AusBiotech Conference, promoting Victoria as a leading global location for biotechnology. You are encouraged to drop by the stand to connect…
